Exploring the Pharmacology of Ginkgo biloba: A Solution for Cardioavascular Disease
https://doi.org/10.25273/florea.v12i1.21388
Keywords:
Ginkgo biloba , Cardiovascular desease , PharmacologyAbstract
Cardiovascular diseases are a leading cause of global mortality, necessitating the exploration of safe and effective treatments. Ginkgo biloba, an ancient medicinal plant, has gained attention for its potential in managing cardiovascular health. This review explores the pharmacological mechanisms of Ginkgo biloba, focusing on its cardiovascular benefits. This review aims to understand the pharmacological mechanisms of Ginkgo biloba in addressing cardiovascular diseases. The method used in this review was a systematic review conducted through the PRISMA guidelines. Ginkgo biloba contains bioactive compounds, including flavonoids, terpenoids, and polysaccharides, that exhibit anti-diabetic, anti-inflammatory, anti-fatty liver hemorrhagic syndrome, anti-oxidant, anti-depressant, and anti-cancer. In conclusion, Ginkgo biloba offers a promising therapeutic solution for cardiovascular desease.
Downloads
References
] M. Unger, "Pharmacokinetic drug interactions involving Ginkgo biloba," Drug Metabolism Reviews, vol. 45, no. 3, pp. 353–385, 2013, doi: 10.3109/03602532.2013.815200.
] Y. Liu, Y. Zhang, and Y. Wang, "Ginkgo biloba extract improves coronary artery circulation in patients with coronary artery disease: A randomized controlled trial," Phytotherapy Research, vol. 34, no. 1, pp. 123-130, 2020, doi: 10.1002/ptr.6495.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Every accepted manuscript should be accompanied by "Copyright Transfer Agreement" prior to the article publication.
Florea : Jurnal Biologi dan Pembelajarannya by http://e-journal.unipma.ac.id/index.php/JF is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Author who publish with this journal agree to the following terms:
- Author not hold and retain copyright and grant the journal of first publication with the work simultaneously licenced under Creative Commons Atribution Licence that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.